Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
- PMID: 15789222
- PMCID: PMC7088045
- DOI: 10.1007/s10096-005-1299-5
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
Abstract
In order to further the present knowledge of the emerging severe acute respiratory syndrome-associated coronavirus (SARS-CoV), 486 different specimens from 54 patients with a clinical diagnosis of SARS were investigated for the presence of viral RNA, and 314 plasma specimens of 73 patients were examined for IgM and IgG antibodies specific against SARS-CoV using an indirect ELISA. Viral RNA was detectable in 28 of the 54 patients tested. Cumulative data showed that 67 of the 73 SARS patients demonstrated seroconversion by week 5 of illness. In contrast, only 1 of 278 healthy subjects enrolled in the study was found to be positive for the IgG antibody. Coexistence of viral RNA in plasma and specific antibodies was simultaneously observed over three consecutive weeks in two critical cases. In three convalescent patients in particular, cultivable SARS-CoV was detected in stool or urine specimens for longer than 4 weeks (29-36 days). These findings suggest that SARS-CoV may remain viable in the excretions of convalescent patients.
Figures
Similar articles
-
[Study on the RNA of severe acute respiratory syndrome (SARS) associated coronavirus in the blood and excretion of convalescent patients with SARS].Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Mar;26(3):201-3. Zhonghua Liu Xing Bing Xue Za Zhi. 2005. PMID: 15941510 Chinese.
-
[Quantitative detection of SARS-CoV RNA in excreta and oropharyngeal washing fluid from convalescence patients with severe acute respiratory syndrome].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):251-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15266825 Chinese.
-
Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital.Emerg Infect Dis. 2004 Oct;10(10):1745-50. doi: 10.3201/eid1010.040026. Emerg Infect Dis. 2004. PMID: 15504259 Free PMC article.
-
[Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing].Zhonghua Er Ke Za Zhi. 2006 Apr;44(4):262-6. Zhonghua Er Ke Za Zhi. 2006. PMID: 16780645 Chinese.
-
Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.J Med Microbiol. 2004 May;53(Pt 5):435-438. doi: 10.1099/jmm.0.45561-0. J Med Microbiol. 2004. PMID: 15096554
Cited by 22 articles
-
Coronaviruses in wastewater processes: Source, fate and potential risks.Environ Int. 2020 Jul 9;143:105962. doi: 10.1016/j.envint.2020.105962. Online ahead of print. Environ Int. 2020. PMID: 32711332 Free PMC article. Review.
-
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?J Thromb Thrombolysis. 2020 Jul 5:1-13. doi: 10.1007/s11239-020-02210-8. Online ahead of print. J Thromb Thrombolysis. 2020. PMID: 32627126 Free PMC article. Review.
-
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11. Am J Med Sci. 2020. PMID: 32620220 Free PMC article. Review.
-
Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients.Infect Drug Resist. 2020 Jun 26;13:1995-2000. doi: 10.2147/IDR.S261159. eCollection 2020. Infect Drug Resist. 2020. PMID: 32617010 Free PMC article. Review.
-
Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration.Epidemiol Infect. 2020 Jun 25;148:e125. doi: 10.1017/S0950268820001399. Epidemiol Infect. 2020. PMID: 32580792 Free PMC article.
References
-
- World Health Organization (2004) Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/. Cited 8 May 2004
-
- Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. doi: 10.1056/NEJMoa030747. - DOI - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. - DOI - PubMed
-
- Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, et al. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Medical
-
Miscellaneous